ARCUTIS BIOTHERAPEUTICS INC (ARQT) Stock Analyst Ratings
NASDAQ:ARQT - Nasdaq - US03969K1088 - Common Stock - Currency: USD
ChartMill assigns a Buy % Consensus number of 85% to ARQT. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 21.57. This target is 43.68% above the current price.
ARQT was analyzed by 13 analysts. The buy percentage consensus is at 85. So analysts seem to be very confident about ARQT.
In the previous month the buy percentage consensus was at a similar level.
ARQT was analyzed by 13 analysts, which is quite many. So the average rating should be quite meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2025-05-23 | Needham | Reiterate | Buy -> Buy |
| 2025-04-09 | Needham | Reiterate | Buy -> Buy |
| 2025-04-03 | Guggenheim | Reiterate | Buy -> Buy |
| 2025-04-03 | Needham | Reiterate | Buy -> Buy |
| 2025-04-03 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2025-03-11 | Jefferies | Maintains | Buy -> Buy |
| 2025-02-27 | Goldman Sachs | Maintains | Neutral -> Neutral |
| 2025-02-26 | Mizuho | Maintains | Outperform -> Outperform |
| 2025-02-26 | Needham | Reiterate | Buy -> Buy |
| 2025-02-26 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2025-02-24 | Guggenheim | Reiterate | Buy -> Buy |
| 2025-02-10 | Guggenheim | Reiterate | Buy -> Buy |
| 2025-01-13 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2025-01-07 | Mizuho | Maintains | Outperform -> Outperform |
| 2024-12-30 | HC Wainwright & Co. | Initiate | Buy |
| 2024-11-07 | Needham | Reiterate | Buy -> Buy |
| 2024-08-28 | Jefferies | Initiate | Buy |
| 2024-08-15 | Needham | Reiterate | Buy -> Buy |
| 2024-07-30 | Needham | Reiterate | Buy -> Buy |
| 2024-07-10 | Needham | Reiterate | Buy -> Buy |
| 2024-05-15 | Mizuho | Maintains | Buy -> Buy |
| 2024-05-15 | Needham | Maintains | Buy -> Buy |
| 2024-04-12 | Needham | Reiterate | Buy -> Buy |
| 2024-02-28 | Mizuho | Reiterate | Buy -> Buy |
| 2024-02-28 | Needham | Maintains | Buy -> Buy |
| 2024-02-28 | Goldman Sachs | Maintains | Neutral -> Neutral |
| 2024-02-23 | Mizuho | Reiterate | Buy -> Buy |
| 2024-01-03 | Mizuho | Upgrade | Neutral -> Buy |
| 2024-01-02 | Mizuho | Upgrade | Neutral -> Buy |
| 2023-11-13 | Morgan Stanley | Maintains | Overweight -> Overweight |